[Drug-eluting or bare-metal stents in interventional cardiology. Theory and practice].
Drug-eluting stents (DES) reduce the restenosis rate after coronary interventions. They became the third milestone of interventional cardiology after coronary angioplasty and stent implantation. However, studies with hard endpoints showing a beneficial effect of DES are still missing. Recent metaanalyses are even suggesting a higher mortality in patients with DES. Now, before DES become avoided, exact indications and limitations have to be defined.